TDR is on the rise after the recent scale-up of ART in Africa. To prevent the development
and spread of drug resistance and sustain the effectiveness of ART programmes, there is a …

Background Infection with the human immunodeficiency virus (HIV) greatly increases the
risk of reactivation tuberculosis. We evaluated the safety and efficacy of three preventive-…

Immune activation during chronic HIV infection is a strong clinical predictor of death and may
mediate CD4+ T cell depletion. Regulatory T cells (Tregs) are CD4+ CD25 bright CD62L …

In the quest for a functional cure or the eradication of HIV infection, it is necessary to know the
sizes of the reservoirs from which infection rebounds after treatment interruption. Thus, we …

Background: There are no validated measures of adherence to HIV antiretroviral therapy in
resource-poor settings. Such measures are essential to understand the unique barriers to …

Treatment interruptions predict resistance in HIV-positive i... : AIDS Treatment interruptions
predict resistance in HIV-positive individuals purchasing fixed-dose combination antiretroviral …

Background There are few data on the epidemiology of primary HIV-1 drug resistance after
the roll-out of antiretroviral treatment (ART) in sub-Saharan Africa. We aimed to assess the …

Background The World Health Organization recommends dolutegravir with two nucleoside
reverse-transcriptase inhibitors (NRTIs) for second-line treatment of human …

Background The efficacy and toxic effects of nucleoside reverse-transcriptase inhibitors (NRTIs)
are uncertain when these agents are used with a protease inhibitor in second-line …

Background The effect of pretreatment HIV-1 drug resistance on the response to first-line
combination antiretroviral therapy (ART) in sub-Saharan Africa has not been assessed. We …